Influence of Anesthetics on Metabolic, Functional and Pathological Responses to Regional Cerebral Ischemia • Regional cerebral ischemia was produced by common carotid artery occlusion in gerbils and by middle cerebral artery occlusion in dogs, cats, and squirrel monkeys. Anesthesia was induced with either pentobarbital or halothane and maintained for two to three hours after vessel occlusion. In acute studies, the effect of regional cerebral ischemia on cerebral concentrations of ATP, phosphocreatine, lactate, and pyruvate was determined at the end of this period in gerbils, cats, and squirrel monkeys. In chronic studies, the degree of neurological deficit and size of cerebral infarction were determined 48 hours after a two-hour to three-hour period of vessel occlusion in cats and squirrel monkeys and permanent occlusion in dogs. In gerbils, dogs, and cats, there were no differences in the metabolic, functional, or pathological effects of anesthesia with pentobarbital or halothane. However, in the squirrel monkey, in acute studies the metabolic alterations were significantly less with pentobarbital, and in chronic studies the frequency and magnitude of functional deficits and cerebral infarction were significantly less. We conclude that pentobarbital does provide a degree of protection during regional cerebral ischemia but that such effects are only consistently demonstrable in primates. In nonprimates, we assume that variability in the collateral circulation renders demonstration of significant differences difficult or impossible. Models of transient total ischemia, wherein a period of cessation of flow occurs, probably cannot be equated to models of regional cerebral ischemia, wherein flow does not immediately cease but rather is markedly decreased to that provided by collateral channels. In a recent study by Smith et al., 3 regional cerebral ischemia was produced in dogs and an apparent protective effect of barbiturates was demonstrated as reflected by decreases in frequency and size of cerebral infarction. In that same study, halothane appeared to have a detrimental effect as evidenced by increases in frequency and size of infarction. The present study represents an effort to examine this question further in various laboratory animals. In these studies, the impact of regional ischemia on the cerebral energy state in the presence of either halothane or pentobarbital anesthesia was examined and correlated with functional and pathological effects.
• Regional cerebral ischemia was produced by common carotid artery occlusion in gerbils and by middle cerebral artery occlusion in dogs, cats, and squirrel monkeys. Anesthesia was induced with either pentobarbital or halothane and maintained for two to three hours after vessel occlusion. In acute studies, the effect of regional cerebral ischemia on cerebral concentrations of ATP, phosphocreatine, lactate, and pyruvate was determined at the end of this period in gerbils, cats, and squirrel monkeys. In chronic studies, the degree of neurological deficit and size of cerebral infarction were determined 48 hours after a two-hour to three-hour period of vessel occlusion in cats and squirrel monkeys and permanent occlusion in dogs. In gerbils, dogs, and cats, there were no differences in the metabolic, functional, or pathological effects of anesthesia with pentobarbital or halothane. However, in the squirrel monkey, in acute studies the metabolic alterations were significantly less with pentobarbital, and in chronic studies the frequency and magnitude of functional deficits and cerebral infarction were significantly less. We conclude that pentobarbital does provide a degree of protection during regional cerebral ischemia but that such effects are only consistently demonstrable in primates. In nonprimates, we assume that variability in the collateral circulation renders demonstration of significant differences difficult or impossible.
Additional Key Words pentobarbital cerebral energy state halothane stroke cerebral protection cerebral infarction species variability
• Among drugs in common clinical usage, anesthetics are perhaps the most potent agents capable of altering normal cerebral hemodynamics and metabolism. Recognition of this has caused some to postulate that anesthetics may exert a cerebral protective effect in the event of an ischemic episode. In animal studies, a limited protective effect has been demonstrated by some investigators in various models of transient total cerebral ischemia. 1 -2 Such an effect has been most consistently demonstrated with barbiturate anesthesia.
Models of transient total ischemia, wherein a period of cessation of flow occurs, probably cannot be equated to models of regional cerebral ischemia, wherein flow does not immediately cease but rather is markedly decreased to that provided by collateral channels. In a recent study by Smith et al., 3 regional cerebral ischemia was produced in dogs and an apparent protective effect of barbiturates was demonstrated as reflected by decreases in frequency and size of cerebral infarction. In that same study, halothane appeared to have a detrimental effect as From the Department of Anesthesia, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55901.
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Address reprint requests to Dr. Michenfelder. evidenced by increases in frequency and size of infarction. The present study represents an effort to examine this question further in various laboratory animals. In these studies, the impact of regional ischemia on the cerebral energy state in the presence of either halothane or pentobarbital anesthesia was examined and correlated with functional and pathological effects.
Methods
Studies were done in 40 Mongolian gerbils, 10 dogs, 30 cats, and 22 squirrel monkeys. In each species, the effects of halothane and pentobarbital on regional cerebral ischemia were compared. Anesthetic circumstances were similar in each comparative study and, when possible, blood gases, arterial pressure, and brain temperature were monitored and differences between comparative groups were minimized.
Gerbils were divided into two groups of 20 each. One group was anesthetized with pentobarbital (40 mg per kilogram intraperitoneally) and the other with halothane (1%). Monitoring in these animals was limited to rectal temperature. After induction of anesthesia, the left common carotid artery was exposed, occluded, and divided. Thereafter, anesthesia was maintained for two hours. At the end of this period, the head of the animal was immersed in liquid nitrogen until freezing was complete and spontaneous ventilation had ceased. With a broad chisel and a sharp blow, the skull and brain were divided in the midline and the left and right cerebral hemispheres were removed and stored at -80°C until the time of preparation for metabolic assays. Dogs were divided into two groups of five each. Anesthesia was induced and maintained with either pentobarbital (40 mg per kilogram intravenously) or halothane (1%). After muscle paralysis was produced with succinylcholine, ventilation was controlled by endotracheal intubation and a Harvard pump. Under an operating microscope, the right middle cerebral artery (MCA) was exposed by a transorbital approach and occluded with a miniaturized Mayfield clip. Thereafter, the dogs were kept anesthetized for three hours while blood gases, esophageal temperature, and arterial blood pressure were monitored and maintained as comparable as possible. After three hours, anesthesia was discontinued, spontaneous ventilation returned, and the trachea was extubated. The animals were returned to their cages, evaluated for 48 hours, and then killed. The brain was removed, fixed in formalin, and, at a later date, sectioned and examined for location and size of infarction.
The cats were divided into four groups: two groups of nine each for acute metabolic studies, and two groups of six each for chronic studies. In both acute and chronic studies, anesthesia was induced and maintained with either pentobarbital (70 mg per kilogram intravenously) or halothane (1%). As in the dog studies, muscle paralysis was produced with succinylcholine, and endotracheal intubation and controlled ventilation with a Harvard pump were instituted. Blood gases, brain temperature (parietal epidural), and arterial blood pressure were monitored. In all animals, the right MCA was clipped via the transorbital approach under an operating microscope. In the acute studies, after three hours of anesthesia the cerebral hemispheres were exposed and bilateral simultaneous brain biopsy specimens were taken from that area of brain normally supplied by the MCA. These specimens were obtained by the technique of Kramer et al., 4 which deposits a 200-mg to 400-mg sample of brain into liquid nitrogen within one second, and were stored at -80°C until the time of assay. In the chronic studies, after three hours of anesthesia the clip was removed from the MCA, anesthesia was discontinued, and, on return of spontaneous ventilation and extubation of the trachea, the animals were returned to their cages and observed for 48 hours. Then they were killed and the brains removed for determination of size and location of infarction.
Squirrel monkeys were divided into four groups as described for the cats. There were five monkeys in each group for the acute studies and six monkeys in each group for the chronic studies. Anesthesia was again either pentobarbital (40 mg per kilogram intraperitoneally) or halothane (1%). The monkeys were paralyzed with succinylcholine, intubated, and ventilated with a Harvard pump. Via the transorbital approach, the right MCA was clipped with the aid of an operating microscope. Blood gases, brain temperature (parietal epidural), and arterial blood pressure were monitored. In the acute studies, anesthesia was maintained for two hours after MCA occlusion; the cerebral hemispheres were then exposed and bilateral brain biopsy specimens were obtained for subsequent assay. In the chronic studies, the MCA clip was removed after two hours of anesthesia and the monkeys were allowed to recover. After 48 hours of observation, the monkeys were killed and the brain was removed for subsequent examination.
For the acute metabolic studies the brain tissue was =* = 0.01
prepared as previously described.
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ATP and phosphocreatine concentrations were measured by the firefly biominescent technique; lactate and pyruvate concentrations were measured by standard enzymatic techniques. In the chronic studies, the brains were sectioned into 5-mm slices, the size of infarction was measured in each slice with a grid, and the total volume of infarct was computed and expressed as a percentage of the volume of that hemisphere.
In the acute metabolic studies, significant differences between pentobarbital and halothane animals were identified by Student's / test for unpaired data. In the chronic studies, significant differences between pentobarbital and halothane animals in degree of neurological deficit and size of infarct were identified by the Wilcoxon two-sample rank test.
Results
In the acute metabolic studies in gerbils, in the chronic studies in dogs, and in both the acute and chronic studies in cats, no significant differences were detected between the effects of halothane and pentobarbital anesthesia on regional cerebral ischemia (tables 1-5).
Only in squirrel monkeys was a significant difference demonstrated (tables 6-8). This difference was consistent in both the acute and chronic studies, indicating that pentobarbital lessened the detrimental effects of MCA occlusion as compared to animals anesthetized with halothane.
In gerbils (table 1), significant decreases in ATP and phosphocreatine and increases in lactate and L/P were observed in the hemisphere made ischemic by common carotid occlusion for two hours. Although the data suggest these changes to be less severe in halothane-anesthetized animals, the differences do not approach significance (P > 0.10). The differences between control hemispheres (in ATP concentrations and body temperatures) may have contributed to these differences in the ischemic hemisphere values.
In the chronic studies in dogs, the great variability in the effects of permanent MCA occlusion on function and frequency and size of infarction is evident in both groups of animals (table 2). Such variability made it unlikely that any significant differences between pentobarbital and halothane could be detected and therefore dictated against further chronic (or acute metabolic) studies in this animal.
A more consistent effect of MCA occlusion (for three hours) was observed in cats. In acute studies, the groups were comparable in regard to systemic variables (table 3) , and the effects of MCA occlusion on ATP, phosphocreatine, lactate, and L/P were similar in the pentobarbital and halothane animals (table 4). In chronic studies, an infarct was found in all cats after three hours of MCA occlusion, and the observed functional deficits and sizes of infarcts were not different between pentobarbital and halothane animals (table 5).
In the acute studies in squirrel monkeys, the groups again were similar in regard to systemic variables (table 6). Two hours of MCA occlusion in these animals resulted in significant alterations in the metabolic determinations, but these changes were significantly less in animals anesthetized with pentobarbital (table 7) . Lactate accumulation was about one-half that observed in halothane animals, and both ATP and phosphocreatine levels were better maintained in the pentobarbital animals. Of interest is the observation that ATP levels also were significantly less in the control hemisphere of halothane animals after a two-hour occlusion of the contralateral MCA. That this is not a primary effect of halothane was demonstrated in two other monkeys maintained anesthetized for two hours with halothane without MCA occlusion: ATP concentrations were greater than 2.0 ^mol per gram in eight separate biopsies. In chronic studies, a difference between halothane and pentobarbital anesthesia was again observed (table 8) . After two hours of MCA occlusion, survival, degree of neurological deficit, and size of infarction all were significantly better in animals anesthetized with pentobarbital.
Discussion
The results indicate that, in a primate model of regional cerebral ischemia, there is a demonstrable difference between the effects of barbiturate anesthesia and halothane anesthesia on the metabolism, function, and viability of ischemic neurons. In nonprimate models, such a difference is either nonexistent or, more likely, nondemonstrable (in a limited number of studies).
For clinical significance, the appropriateness of a model of regional cerebral ischemia is largely determined by the degree to which that model compares to man. In this regard, the anatomical similarities between the cerebral circulation in the model and in man are most critical. In the squirrel monkey (and probably all primates), the anatomical similarities are such that MCA occlusion can be expected to result in a consistent cerebral infarction similar in relative size and distribution to that seen in man.
6 This is not a consistent observation in nonprimate laboratory animals. This difference presumably relates to the considerable variation in collateral flow in nonprimates. If the collateral flow is unpredictable, it follows that the effects of single-vessel occlusion will be unpredictable and, hence, the ability to detect a difference between groups of animals treated differently will be obscured -even if the difference is real. Of perhaps equal im- portance is the technique used to produce regional ischemia. It should be obvious that the technique must be as atraumatic as possible so as not to introduce the complications resulting from brain retraction, hematoma formation, etc. The transorbital approach to the MCA offers such an atraumatic approach in that no brain retraction is required, bleeding is easily controlled, and the occluding device remains largely extradural.
We selected a two-hour period of MCA occlusion in the squirrel monkey because of previous studies that demonstrated that occlusion for up to two hours was tolerated by about 50% of the animals with little or no subsequent infarction (with pentobarbital anesthesia). Furthermore, we had shown that ATP concentration decreased progressively during that two-hour period to about 50% of control but that, with removal of the clip, it returned toward the control value (again, with pentobarbital anesthesia). Similarly, lactate accumulation was reversed with the re-establishment of flow. Thus, we expected that any differences between halothane and pentobarbital should be demonstrable by comparisons made after two hours of occlusion.
The differences shown do not of themselves permit a conclusion as to whether pentobarbital protects ischemic brain or whether halothane is detrimental to ischemic brain. The study by Smith et al. 3 suggests that both conclusions may be correct because, compared to their "awake" animals, barbiturate-treated animals had fewer and smaller infarctions whereas halothane-treated animals demonstrated a doserelated increase in the frequency and the size of infarction.
At least two mechanisms might account for how an anesthetic can alter the impact of single-vessel occlusion on the brain. Most anesthetics depress cerebral metabolic rates, barbiturates being the most potent depressants in clinically useful concentrations. In areas of regional ischemia, oxygen delivery and neuronal viability are dependent on collateral flow. If oxygen requirements can be decreased to levels that more closely match the rate of oxygen delivery, it might be possible to interrupt the vicious circle of lactate accumulation, edema formation, intracranial pressure (ICP) increase, and further decrease in *Data shown as means ± SE; N = 5 in each group. fFor all values in column, for difference from corresponding control, P < 0.01. {For difference from pentobarbital control value, P < 0.01.
§For difference from pentobarbital MCA-occluded value, P < 0.07. ||For difference fiom pentobarbital MCA-occluded value, P < 0.01.
collateral flow. If this were the major or only mechanism, then halothane as well as barbiturates should provide a degree of protection. That halothane apparently does not protect suggests that there is either a different or an additional mechanism. A major difference between barbiturates and halothane is their effect on cerebral blood flow. Barbiturates decrease blood flow to nonischemic brain, whereas halothane is a known cerebral vasodilator. 9 Thus, in regional ischemia, decreased flow to nonischemic brain will decrease intracranial blood volume and, if the change is sufficient, this might minimize ICP increases and maintain a more adequate collateral flow. An opposite effect would occur with halothane.
It is likely that the protective effect of barbiturates depends on both mechanisms. These same mechanisms probably account for the observation that barbiturates decrease edema formation after creation of an intracerebral cryogenic lesion.
10 If these are the basic mechanisms, then it must be assumed that halothane's detrimental cerebral vascular effects overwhelm its potentially beneficial cerebral metabolic effects with a resultant increase in ICP and decrease in collateral flow. That this might be the case is suggested by our results showing a decrease in ATP in the control hemisphere two hours after occlusion of the contralateral MCA of squirrel monkeys anesthetized with halothane. This is most easily explained by an increase in ICP sufficient to decrease flow to both hemispheres. That flow to the ischemic hemisphere does progressively decrease during halothane anesthesia has been observed in a separate study (Hanson and Sundt: unpublished data) . Such a progressive decrease in flow is not seen during the initial two hours of ischemia with pentobarbital anesthesia.
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If these are the primary mechanisms whereby anesthetics can alter the effects of regional cerebral ischemia, then such mechanisms should be operative in nonprimates as well. Certainly in both dogs and cats, halothane and barbiturates have cerebral vascular and metabolic effects similar to those seen in primates. Our failure to observe significant differences in these animals suggests that the variability of the ischemic lesion itself is such as to obliterate detection of either beneficial or detrimental effects of anesthetics. Smith et al. 3 did detect such effects in their study of dogs. Possibly, the ischemic lesion they produced was more consistent because they occluded both the internal carotid artery and the MCA, the latter being approached by a temporal burr hole and requiring brain retraction and presumably a degree of regional trauma. 
